
Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer Sonam Kumari, Shilpa Thakur, Stephanie…
Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer Sonam Kumari, Shilpa Thakur, Stephanie…
FOR IMMEDIATE RELEASE FROM MARY ANN LIEBERT, INC., PUBLISHERS New Rochelle, NY, January 8, 2025—A…
From Clinical Thyroidology® for the Public: In many cases, the dose of thyroid hormone required…
The Thyroid Stimulating Podcast was created in partnership with the American Thyroid Association® and Medscape…
The Official Journal of: American Thyroid Association® Differential Ultrasound Rates Mirror Sex Disparities in Thyroid…
Will Climate Change Impact Patients with Thyroid Dysfunction? Christopher W. Rowe and Nicholas J. Talley
Towards Personalized TSH Reference Ranges: A Genetic and Population-Based Approach in Three Independent Cohorts Aleksander…
As 2024 comes to a close, we would like to take the opportunity to share…
From Clinical Thyroidology® for the Public: Proton-pump inhibitors (PPIs) lower the amount of acid the…
FOR IMMEDIATE RELEASE December 6, 2024 Contact: Hayley Gray-Hoehn, hayley.gray-hoehn@mail.house.gov Washington, D.C. – Wednesday, U.S….